The FINANCIAL — Investment funds managed by Morgan Stanley Capital Partners (“MSCP”), a Private Equity team within Morgan Stanley Investment Management, announced that they have completed an investment in US HealthConnect (“USHC” or the “Company”). MSCP is partnering with the current management team led by Frank Russomano, who will remain President and CEO and continue to drive platform expansion during the investment.
USHC is a pioneering digital platform providing pharma-sponsored continuing medical education and promotional education to healthcare providers. Founded in 1999, the Company has evolved into an industry leader in digital medical education focusing on diversified areas such as oncology, cardiology, and women’s health. USHC uses its unique, data-driven strategic and consultative approach to help pharmaceutical clients meet the information needs of healthcare providers. USHC represents a continuation of MSCP’s focus on high-growth, founder-owned companies.
Steve Rodgers, Managing Director of Morgan Stanley Capital Partners, said, “We are delighted to be partnering with USHC’s talented management team led by Frank. The Company has distinguished itself with a best-in-class approach to providing healthcare providers with unique learning platforms and personalized education experiences. We look forward to building on its success delivering targeted engagement not possible in traditional marketing channels.”
Frank Russomano, Chief Executive Officer of US Health Connect, said: “We are pleased to pursue the next growth phase for USHC with Morgan Stanley Capital Partners. Morgan Stanley’s deep industry knowledge and history of supporting founders in platform expansion makes this an ideal partnership. Together we can meet the increasing demand for USHC’s capabilities and drive value to clients through our award-winning digital solutions. Our entire management team is excited to work together to expand the reach of our differentiated platform.”
Discussion about this post